vs
Esperion Therapeutics, Inc.（ESPR）与KADANT INC（KAI）财务数据对比。点击上方公司名可切换其他公司
KADANT INC的季度营收约是Esperion Therapeutics, Inc.的1.6倍（$271.6M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -0.0%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 6.7%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Kadant Inc.创立于1991年，最初是Thermo Electron的子公司，部分股权私有、部分公开交易，2001年完成完全分拆并启用现名。公司服务于造纸、废纸回收、木材加工、物料搬运等多个加工领域，是业务覆盖亚洲、欧洲、北美、南美的跨国企业。
ESPR vs KAI — 直观对比
营收规模更大
KAI
是对方的1.6倍
$168.4M
营收增速更快
ESPR
高出143.7%
-0.0%
两年增速更快
ESPR
近两年复合增速
6.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $271.6M |
| 净利润 | — | $27.7M |
| 毛利率 | — | 45.2% |
| 营业利润率 | 50.6% | 15.7% |
| 净利率 | — | 10.2% |
| 营收同比 | 143.7% | -0.0% |
| 净利润同比 | — | -12.2% |
| 每股收益（稀释后） | $0.32 | $2.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRKAI
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $271.6M | ||
| Q2 25 | $82.4M | $255.3M | ||
| Q1 25 | $65.0M | $239.2M | ||
| Q4 24 | $69.1M | $258.0M | ||
| Q3 24 | $51.6M | $271.6M | ||
| Q2 24 | $73.8M | $274.8M | ||
| Q1 24 | $137.7M | $249.0M |
净利润ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $27.7M | ||
| Q2 25 | $-12.7M | $26.2M | ||
| Q1 25 | $-40.5M | $24.1M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | $-29.5M | $31.6M | ||
| Q2 24 | $-61.9M | $31.3M | ||
| Q1 24 | $61.0M | $24.7M |
毛利率ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 45.2% | ||
| Q2 25 | — | 45.9% | ||
| Q1 25 | — | 46.1% | ||
| Q4 24 | — | 43.4% | ||
| Q3 24 | — | 44.7% | ||
| Q2 24 | — | 44.4% | ||
| Q1 24 | — | 44.6% |
营业利润率ESPRKAI
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | 15.7% | ||
| Q2 25 | 8.6% | 15.4% | ||
| Q1 25 | -34.0% | 14.9% | ||
| Q4 24 | -6.4% | 14.3% | ||
| Q3 24 | -31.0% | 18.0% | ||
| Q2 24 | 3.5% | 17.6% | ||
| Q1 24 | 52.5% | 14.8% |
净利率ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 10.2% | ||
| Q2 25 | -15.4% | 10.2% | ||
| Q1 25 | -62.2% | 10.1% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | -57.2% | 11.6% | ||
| Q2 24 | -83.9% | 11.4% | ||
| Q1 24 | 44.3% | 9.9% |
每股收益（稀释后）ESPRKAI
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $2.35 | ||
| Q2 25 | $-0.06 | $2.22 | ||
| Q1 25 | $-0.21 | $2.04 | ||
| Q4 24 | $-0.14 | $2.04 | ||
| Q3 24 | $-0.15 | $2.68 | ||
| Q2 24 | $-0.33 | $2.66 | ||
| Q1 24 | $0.34 | $2.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $124.5M |
| 总债务越低越好 | — | $254.6M |
| 股东权益账面价值 | $-302.0M | $949.8M |
| 总资产 | $465.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资ESPRKAI
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | $124.5M | ||
| Q2 25 | $86.1M | $95.3M | ||
| Q1 25 | $114.6M | $91.7M | ||
| Q4 24 | $144.8M | $94.7M | ||
| Q3 24 | $144.7M | $88.4M | ||
| Q2 24 | $189.3M | $73.8M | ||
| Q1 24 | $226.6M | $81.4M |
总债务ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | $254.6M | ||
| Q2 25 | — | $245.7M | ||
| Q1 25 | — | $273.5M | ||
| Q4 24 | — | $285.2M | ||
| Q3 24 | — | $323.2M | ||
| Q2 24 | — | $342.0M | ||
| Q1 24 | — | $306.8M |
股东权益ESPRKAI
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $949.8M | ||
| Q2 25 | $-433.5M | $926.0M | ||
| Q1 25 | $-426.2M | $876.0M | ||
| Q4 24 | $-388.7M | $847.1M | ||
| Q3 24 | $-370.2M | $851.7M | ||
| Q2 24 | $-344.2M | $807.7M | ||
| Q1 24 | $-294.3M | $782.7M |
总资产ESPRKAI
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $1.5B | ||
| Q2 25 | $347.1M | $1.5B | ||
| Q1 25 | $324.0M | $1.4B | ||
| Q4 24 | $343.8M | $1.4B | ||
| Q3 24 | $314.1M | $1.5B | ||
| Q2 24 | $352.3M | $1.5B | ||
| Q1 24 | $373.1M | $1.4B |
负债/权益比ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.31× | ||
| Q4 24 | — | 0.34× | ||
| Q3 24 | — | 0.38× | ||
| Q2 24 | — | 0.42× | ||
| Q1 24 | — | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $47.3M |
| 自由现金流经营现金流 - 资本支出 | — | $44.1M |
| 自由现金流率自由现金流/营收 | — | 16.2% |
| 资本支出强度资本支出/营收 | 0.0% | 1.2% |
| 现金转化率经营现金流/净利润 | — | 1.70× |
| 过去12个月自由现金流最近4个季度 | — | $145.9M |
8季度趋势，按日历期对齐
经营现金流ESPRKAI
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $47.3M | ||
| Q2 25 | $-31.4M | $40.5M | ||
| Q1 25 | $-22.6M | $22.8M | ||
| Q4 24 | $-35.0M | $51.9M | ||
| Q3 24 | $-35.3M | $52.5M | ||
| Q2 24 | $-7.2M | $28.1M | ||
| Q1 24 | $53.8M | $22.8M |
自由现金流ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | $44.1M | ||
| Q2 25 | — | $36.5M | ||
| Q1 25 | — | $19.0M | ||
| Q4 24 | — | $46.3M | ||
| Q3 24 | $-35.5M | $48.3M | ||
| Q2 24 | $-7.3M | $23.1M | ||
| Q1 24 | $53.8M | $16.6M |
自由现金流率ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | — | 14.3% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 17.9% | ||
| Q3 24 | -68.7% | 17.8% | ||
| Q2 24 | -9.9% | 8.4% | ||
| Q1 24 | 39.0% | 6.7% |
资本支出强度ESPRKAI
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | 0.0% | 1.6% | ||
| Q1 25 | 0.0% | 1.6% | ||
| Q4 24 | 0.0% | 2.2% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | 0.1% | 2.5% |
现金转化率ESPRKAI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.55× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 0.90× | ||
| Q1 24 | 0.88× | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
KAI
| Flow Control | $94.8M | 35% |
| Capital | $83.2M | 31% |
| Material Handling Systems | $70.3M | 26% |
| Transferred Over Time | $17.1M | 6% |
| Other | $6.1M | 2% |
